Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2004 | 07-2004 | 04-2004 | 01-2004 | 10-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 31,600 | 18,000 | 13,200 | 16,300 | -39,800 |
| Depreciation Amortization | 40,900 | 28,900 | 18,900 | 9,900 | 53,400 |
| Income taxes - deferred | 1,900 | N/A | N/A | N/A | N/A |
| Accounts receivable | -7,000 | 8,600 | 1,800 | 11,700 | 1,900 |
| Accounts payable and accrued liabilities | 800 | -1,700 | 4,700 | 500 | -29,500 |
| Other Working Capital | 10,700 | -14,300 | 6,800 | -200 | -3,000 |
| Other Operating Activity | -71,000 | -58,400 | -48,700 | -44,400 | 49,000 |
| Operating Cash Flow | $7,900 | $-18,900 | $-3,300 | $-6,200 | $32,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 93,800 | -213,300 | -217,800 | N/A |
| PPE Investments | -3,200 | 400 | -1,000 | 2,700 | -67,600 |
| Net Acquisitions | -227,300 | -288,700 | 3,700 | 5,000 | 1,900 |
| Purchase Of Investment | -2,073,200 | N/A | N/A | N/A | -652,200 |
| Sale Of Investment | 2,115,900 | N/A | N/A | N/A | 159,500 |
| Other Investing Activity | -4,600 | -4,200 | -2,400 | -200 | 161,400 |
| Investing Cash Flow | $-192,400 | $-198,700 | $-213,000 | $-210,300 | $-397,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -10,700 | N/A | N/A | N/A | 371,700 |
| Debt Repayment | N/A | -10,200 | -8,300 | -800 | N/A |
| Common Stock Issued | 3,700 | 3,300 | 4,600 | 1,800 | 8,200 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -34,500 |
| Financing Cash Flow | $-7,000 | $-6,900 | $-3,700 | $1,000 | $345,400 |
| Exchange Rate Effect | -200 | -900 | -100 | -100 | 800 |
| Beginning Cash Position | 255,500 | 285,600 | 288,800 | 288,100 | 276,700 |
| End Cash Position | 63,800 | 60,200 | 68,700 | 72,500 | 257,900 |
| Net Cash Flow | $-191,700 | $-225,400 | $-220,100 | $-215,600 | $-18,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,900 | -18,900 | -3,300 | -6,200 | 32,000 |
| Capital Expenditure | -14,400 | -10,400 | -6,600 | -2,900 | -69,500 |
| Free Cash Flow | -6,500 | -29,300 | -9,900 | -9,100 | -37,500 |